Australia markets close in 1 hour 19 minutes
  • ALL ORDS

    7,270.90
    +39.90 (+0.55%)
     
  • ASX 200

    7,012.20
    +35.30 (+0.51%)
     
  • AUD/USD

    0.7668
    +0.0021 (+0.27%)
     
  • OIL

    60.65
    +0.47 (+0.78%)
     
  • GOLD

    1,744.30
    -3.30 (-0.19%)
     
  • BTC-AUD

    83,307.80
    +3,872.43 (+4.87%)
     
  • CMC Crypto 200

    1,379.57
    +85.58 (+6.61%)
     
  • AUD/EUR

    0.6408
    +0.0013 (+0.20%)
     
  • AUD/NZD

    1.0811
    -0.0019 (-0.17%)
     
  • NZX 50

    12,719.38
    +62.98 (+0.50%)
     
  • NASDAQ

    13,986.49
    +167.09 (+1.21%)
     
  • FTSE

    6,890.49
    +1.37 (+0.02%)
     
  • Dow Jones

    33,677.27
    -68.13 (-0.20%)
     
  • DAX

    15,234.36
    +19.36 (+0.13%)
     
  • Hang Seng

    28,850.00
    +352.75 (+1.24%)
     
  • NIKKEI 225

    29,642.20
    -109.40 (-0.37%)
     

Why Inovio's Positive Q4 Update Didn't Impress Investors

Keith Speights, The Motley Fool
·3-min read
Why Inovio's Positive Q4 Update Didn't Impress Investors

Inovio Pharmaceuticals (NASDAQ: INO) shares are up nearly 25% year to date. That's great -- except the stock was up more than 90% in early February. Investors hoping for good news got some with Inovio's fourth-quarter update after the market closed on Monday.